We want to create a future where healthcare meets patients where they are, not where diagnostics want them to be.
The pandemic showed us the need for remote monitoring solutions in oncology. That is why we are developing a home-based low-cost device to measure complete blood count and metabolic panel. By automating and optimizing the workflow of blood tests for side-effect monitoring, our team is working towards enabling decentralized health-care.
Mission
The pandemic accelerated the shift of clinical trials to the virtual space. However, trial participants are still required to travel physically to the sites for blood draws and analysis, creating geographical barriers to participation and adding to the burden on trial participants. In fact, collecting and analyzing blood is one of the big gaps between conventional and virtual clinical trials.
To close this gap, we are developing a home-based low-cost device to measure complete blood count and metabolic panel. By automating and optimizing the workflow of blood tests, our team is working towards enabling decentralized clinical trials.
In the future, we want to bring our remote patient monitoring technologies to the clinic to transform routine diagnostics.
Vision
To create a future where healthcare meets patients where they are, not where diagnostics want them to be
Team
Iris Wing To Lam
Product development
Antonio Lee
Software development
Julian Bitzmann
Business development
Dr. med. Susanne Holzhauer
Oncology/Hematology advisor
Ask
– Partnerships with CROs and pharma companies to explore the application in virtual or hybrid clinical trials
– Team members for regulatory affairs and UI/UX design
– Co-development and/or cooperation partnerships for assay development
Contact
If you want to join our voyage or have an inquiry about our project, we would love to get in touch with you. You can just drop us a mail at
iris-wing-to.lam@charite.de
We want to create a future where healthcare meets patients where they are, not where diagnostics want them to be.
The pandemic showed us the need for remote monitoring solutions in oncology. That is why we are developing a home-based low-cost device to measure complete blood count and metabolic panel. By automating and optimizing the workflow of blood tests for side-effect monitoring, our team is working towards enabling decentralized health-care.
Mission
The pandemic accelerated the shift of clinical trials to the virtual space. However, trial participants are still required to travel physically to the sites for blood draws and analysis, creating geographical barriers to participation and adding to the burden on trial participants. In fact, collecting and analyzing blood is one of the big gaps between conventional and virtual clinical trials.
To close this gap, we are developing a home-based low-cost device to measure complete blood count and metabolic panel. By automating and optimizing the workflow of blood tests, our team is working towards enabling decentralized clinical trials.
In the future, we want to bring our remote patient monitoring technologies to the clinic to transform routine diagnostics.
Vision
To create a future where healthcare meets patients where they are, not where diagnostics want them to be
Team
Iris Wing To Lam
Product development
Antonio Lee
Software development
Julian Bitzmann
Business development
Dr. med. Susanne Holzhauer
Oncology/Hematology advisor
Ask
– Partnerships with CROs and pharma companies to explore the application in virtual or hybrid clinical trials
– Team members for regulatory affairs and UI/UX design
– Co-development and/or cooperation partnerships for assay development
Contact
If you want to join our voyage or have an inquiry about our project, we would love to get in touch with you. You can just drop us a mail at
iris-wing-to.lam@charite.de